Copyright Reports & Markets. All rights reserved.

Global Monogenetic Disorders Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Monogenetic Disorders Testing Market Overview

    • 1.1 Product Overview and Scope of Monogenetic Disorders Testing
    • 1.2 Classification of Monogenetic Disorders Testing by Type
      • 1.2.1 Global Monogenetic Disorders Testing Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Monogenetic Disorders Testing Revenue Market Share by Type in 2019
      • 1.2.3 Carrier Testing
      • 1.2.4 Diagnostic Testing
      • 1.2.5 New-Born Screening
      • 1.2.6 Predictive & Pre-Symptomatic Testing
      • 1.2.7 Prenatal Testing
      • 1.2.8 Others
    • 1.3 Global Monogenetic Disorders Testing Market by Application
      • 1.3.1 Overview: Global Monogenetic Disorders Testing Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Hospitals
      • 1.3.3 Specialized Clinics
      • 1.3.4 Ambulatory Surgical Centers
    • 1.4 Global Monogenetic Disorders Testing Market by Regions
      • 1.4.1 Global Monogenetic Disorders Testing Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Monogenetic Disorders Testing (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Monogenetic Disorders Testing Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Monogenetic Disorders Testing Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Monogenetic Disorders Testing Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Monogenetic Disorders Testing Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Monogenetic Disorders Testing Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Celera Group
      • 2.1.1 Celera Group Details
      • 2.1.2 Celera Group Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Celera Group SWOT Analysis
      • 2.1.4 Celera Group Product and Services
      • 2.1.5 Celera Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Roche
      • 2.2.1 Roche Details
      • 2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Roche SWOT Analysis
      • 2.2.4 Roche Product and Services
      • 2.2.5 Roche Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 ELITech Group
      • 2.3.1 ELITech Group Details
      • 2.3.2 ELITech Group Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 ELITech Group SWOT Analysis
      • 2.3.4 ELITech Group Product and Services
      • 2.3.5 ELITech Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Abbott
      • 2.4.1 Abbott Details
      • 2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Abbott SWOT Analysis
      • 2.4.4 Abbott Product and Services
      • 2.4.5 Abbott Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 PerkinElmer
      • 2.5.1 PerkinElmer Details
      • 2.5.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 PerkinElmer SWOT Analysis
      • 2.5.4 PerkinElmer Product and Services
      • 2.5.5 PerkinElmer Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Thermo Fisher Scientific
      • 2.6.1 Thermo Fisher Scientific Details
      • 2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Thermo Fisher Scientific SWOT Analysis
      • 2.6.4 Thermo Fisher Scientific Product and Services
      • 2.6.5 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Transgenomic
      • 2.7.1 Transgenomic Details
      • 2.7.2 Transgenomic Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Transgenomic SWOT Analysis
      • 2.7.4 Transgenomic Product and Services
      • 2.7.5 Transgenomic Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 AutoGenomics
      • 2.8.1 AutoGenomics Details
      • 2.8.2 AutoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 AutoGenomics SWOT Analysis
      • 2.8.4 AutoGenomics Product and Services
      • 2.8.5 AutoGenomics Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Quest
      • 2.9.1 Quest Details
      • 2.9.2 Quest Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Quest SWOT Analysis
      • 2.9.4 Quest Product and Services
      • 2.9.5 Quest Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Bio-Rad
      • 2.10.1 Bio-Rad Details
      • 2.10.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Bio-Rad SWOT Analysis
      • 2.10.4 Bio-Rad Product and Services
      • 2.10.5 Bio-Rad Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Monogenetic Disorders Testing Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Monogenetic Disorders Testing Players Market Share
      • 3.2.2 Top 10 Monogenetic Disorders Testing Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Monogenetic Disorders Testing Revenue and Market Share by Regions
    • 4.2 North America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 4.5 South America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

    5 North America Monogenetic Disorders Testing Revenue by Countries

    • 5.1 North America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
    • 5.2 USA Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

    6 Europe Monogenetic Disorders Testing Revenue by Countries

    • 6.1 Europe Monogenetic Disorders Testing Revenue by Countries (2015-2020)
    • 6.2 Germany Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 6.3 UK Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 6.4 France Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries

    • 7.1 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries (2015-2020)
    • 7.2 China Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 7.5 India Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

    8 South America Monogenetic Disorders Testing Revenue by Countries

    • 8.1 South America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
    • 8.2 Brazil Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Monogenetic Disorders Testing by Countries

    • 9.1 Middle East & Africa Monogenetic Disorders Testing Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Monogenetic Disorders Testing Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Monogenetic Disorders Testing Market Forecast by Type (2019-2024)
    • 10.3 Carrier Testing Revenue Growth Rate (2015-2025)
    • 10.4 Diagnostic Testing Revenue Growth Rate (2015-2025)
    • 10.5 New-Born Screening Revenue Growth Rate (2015-2025)
    • 10.6 Predictive & Pre-Symptomatic Testing Revenue Growth Rate (2015-2025)
    • 10.7 Prenatal Testing Revenue Growth Rate (2015-2025)
    • 10.8 Others Revenue Growth Rate (2015-2025)

    11 Global Monogenetic Disorders Testing Market Segment by Application

    • 11.1 Global Monogenetic Disorders Testing Revenue Market Share by Application (2015-2020)
    • 11.2 Monogenetic Disorders Testing Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2015-2020)
    • 11.4 Specialized Clinics Revenue Growth (2015-2020)
    • 11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)

    12 Global Monogenetic Disorders Testing Market Size Forecast (2021-2025)

    • 12.1 Global Monogenetic Disorders Testing Market Size Forecast (2021-2025)
    • 12.2 Global Monogenetic Disorders Testing Market Forecast by Regions (2021-2025)
    • 12.3 North America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
    • 12.4 Europe Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
    • 12.6 South America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Market Overview
      The global Monogenetic Disorders Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

      The Monogenetic Disorders Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Monogenetic Disorders Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, Monogenetic Disorders Testing market has been segmented into:
      Carrier Testing
      Diagnostic Testing
      New-Born Screening
      Predictive & Pre-Symptomatic Testing
      Prenatal Testing
      Others

      By Application, Monogenetic Disorders Testing has been segmented into:
      Hospitals
      Specialized Clinics
      Ambulatory Surgical Centers

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Monogenetic Disorders Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Monogenetic Disorders Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Monogenetic Disorders Testing market.

      The report offers in-depth assessment of the growth and other aspects of the Monogenetic Disorders Testing market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Competitive Landscape and Monogenetic Disorders Testing Market Share Analysis
      Monogenetic Disorders Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Monogenetic Disorders Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Monogenetic Disorders Testing sales, revenue and market share for each player covered in this report.

      The major players covered in Monogenetic Disorders Testing are:
      Celera Group
      Roche
      ELITech Group
      Abbott
      PerkinElmer
      Thermo Fisher Scientific
      Transgenomic
      AutoGenomics
      Quest
      Bio-Rad

      Buy now